XETRA:GXI

Gerresheimer AG · XETRA · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 13:27 UTC

Last close

n/aEUR

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-13.8%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
-4.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.48Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.2%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.23 against 0.58 on the market's range.

All from 100

lens 2 of 9

Sales

169

2016-11-30 to 2025-11-30100 at the start169

Sales: 100.00 on 2016-11-30 to 168.74 on 2025-11-30, up 69%.

Profit

-263

2016-11-30 to 2025-11-30100 at the start-263

Profit: 100.00 on 2016-11-30 to -263.34 on 2025-11-30, down 363%.

Shares in issue

110

2016-11-30 to 2025-11-30100 at the start110

Shares in issue: 100.00 on 2016-11-30 to 110.04 on 2025-11-30, up 10%.

Sales is at 169, Profit is at -263, Shares in issue is at 110, against 100 in 2016.

Sales is at 169, Profit is at -263, Shares in issue is at 110, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100169
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Profit, where the first year is 100-263
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Shares in issue, where the first year is 100110
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR